BDSX Medical Testing name that is undervalued

u/Tripper4432 · Reddit — r/pennystocks · January 03, 2026 at 13:58 · ⬆ 1 pts · 💬 2 comments  | View on Reddit ↗
AI Summary

Original Reddit post

Author argues BDSX is undervalued below 1x forward sales given expected EBITDA inflection and 25%+ revenue growth.

BDSX — LONG BDSX is guided to rotate from EBITDA negative to EBITDA positive in Q4 and then likely positive all 2026. Revenue is growing 25%+ in the medical testing industry. The author believes it should trade at 4x to 5x forward sales like peers such as WGS, but currently trades below 1x forward sales, implying significant upside as the market reprices it.

BDSX guided to rotating from EBITDA negative to EBITDA positive in Q4 and then probably positive all 2026. Revenue growing 25%+ in the medical testing industry. Feels like that should trade 4x to 5x forward sales, like WGS and others. While it currently trades below 1x forward sales.

Score 1
Comments 2
▶ Full Post Text
Ideas
u/Tripper4432 Reddit r/pennystocks
Undervalued medical testing name with EBITDA inflection and revenue growth
BDSX is guided to rotate from EBITDA negative to EBITDA positive in Q4 and then likely positive all 2026. Revenue is growing 25%+ in the medical testing industry. The author believes it should trade at 4x to 5x forward sales like peers such as WGS, but currently trades below 1x forward sales, implying significant upside as the market reprices it.
BDSX HIGH
More from Reddit — r/pennystocks
$GPUS: Insider buy alert, Why Is the CEO Accumulating tons and tons of shares?
Jan 03, 12:29
XTI Aerospace Inc.
Jan 03, 11:45
Equus Energy (ASX:EQU)
Jan 03, 07:42
Retirement income/Investments
Jan 03, 07:03
US Army deal with UAVS - drone stock
Jan 03, 03:20

This Reddit post, published January 03, 2026, features u/Tripper4432 discussing BDSX. 1 trade idea extracted by AI with direction and confidence scoring.

Speakers: u/Tripper4432  · Tickers: BDSX